HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹221 Cr | ₹1705 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 04 Oct 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Dhruv Muchhal |
ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Month | 3.64% | 3.97% |
6 Month | -6.54% | -2.01% |
1 Year | 15.59% | 27.16% |
3 Year | 23.7% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
6 Month | 5.42% | 6.78% |
1 Year | 3.19% | 11.95% |
3 Year | 22.52% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 20.48% | 34.78% |
3 Year | 18.71% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 15.61% | - |
Sharp | 0.93% | - |
Beta | 0.94% | - |
Alpha | -0.87% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Dhruv Muchhal |
Total AUM | ₹4626 Cr | ₹520687 Cr |
Funds Managed | 10 | 40 |
ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.38 | 5.67 |
Mid Cap | 34.93 | 26.59 |
Small Cap | 33.22 | 33.75 |
Large Cap | 30.47 | 33.98 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 0.29 | 2.02 |
Healthcare | 95.15 | 95.78 |
Basic Materials | 3.63 | 2.2 |
Industrials | 0.93 | - |
Top Comparisons
HDFC Flexi Cap Fund - Growth Plan
3Y Returns27.58%
Aditya Birla Sun Life Flexi Cap Fund - Growth - Regular Plan
3Y Returns21.85%
HSBC Aggressive Hybrid Active FOF - Growth
3Y Returns19.17%
Mirae Asset Equity allocator Fund Of Fund Regular Growth
3Y Returns20.92%
Franklin India Feeder - Franklin U.S. Opportunities Fund - Growth
3Y Returns21.52%
DSP US Flexible Equity Fund - Regular Plan - Growth
3Y Returns18.82%
Invesco India Infrastructure Fund - Growth Option
3Y Returns32.27%
Sundaram Infrastructure Advantage Fund Regular Plan - Growth
3Y Returns28.43%